Former Medical Device Analyst
For over 20 years Thom Gunderson was a managing director and senior research analyst at Piper Jaffray, following medical technology companies. Gunderson has been recognized by several industry publications, including the Wall Street Journal, Institutional Investor, First Call, and Medical Device and Diagnostic Industry. In 2014, Thomson-Reuters named him “Top Stock Picker” in the medical technology sector. Having retired in early 2016, Gunderson is currently Chairman of the Board of Directors at the Minneapolis Heart Institute Foundation, an Executive in Residence at the University of Minnesota’s Medical Industry Leadership Institute, and a member of the American Heart Association’s Science and Technology Accelerator Committee. He holds a Bachelor’s degree from Carleton College, and graduate degrees in cell biology and business administration.